ANEUVO (NASDAQ: ANEU) Gains FDA Clearance for ExaStim® Device
Key Developments ANEUVO (NASDAQ: ANEU) has received FDA clearance for its ExaStim® device, marking a major milestone for the company as it prepares to enter the U.S. market. This clearance represents a significant step forward in offering accessible non-invasive neuromodulation therapy both in clinical settings and for at-home use. The approval supports ANEUVO’s global mission to expand availability of innovative neuromodulation treatments that are less invasive and can be widely…
